Back

Assessment and contributing factors of adequate endothelization after drug-eluting stent implantation

29 August 2026 (08:15 - 08:40)
Organised by: Logo
Congress Presentation Part of: Precision cardiology by and beyond optical coherence tomography: integrating imaging, artificial intelligence, and biomarkers for plaque assessment Optical Coherence Tomography ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Masami Nishino

Osaka Rosai Hospital, Sakai (Japan)

3 More presentations in this session

Presentation thumbnail
Artificial intelligence-based analysis of stent malapposition and expansion from intracoronary optical coherence tomography
Mr X. Gu (Amsterdam, NL)
Abstract
Presentation thumbnail
A “foundation model” for precision coronary plaque phenotyping: integration of multi-modal imaging, laboratory, and clinical data via contrastive learning
Doctor S. Andreaggi (Boston, US)
Abstract
Presentation thumbnail
The association between non-Lp(a)-ApoB / Lp(a) ratio and plaque vulnerability according to lipid oxidation status
Doctor T. Ishigaki (Ishinomaki, JP)
Abstract

Access the full session

Session thumbnail
Precision cardiology by and beyond optical coherence tomography: integrating imaging, artificial intelligence, and biomarkers for plaque assessment

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Indirect evaluation of device-endothelialization with cardiac-CT after transcatheter closure of atrial septal defect: How long should antiplatelet therapy last postoperatively?
28 August 2020
thumbnail
Congress Presentation
Zotarolimus-eluting stent in complex lesions versus non-complex lesions from Japanese all-comers registry
1 September 2025
thumbnail
Congress Presentation
Thromboelastography-based assessment of thrombus burden in STEMI
20 March 2026
thumbnail
Congress Presentation
Serial OCT assessment after directional coronary atherectomy followed by drug-coated balloon: 3 months, 7 months, and 1.5 years
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources